Letrozole
Oxidative Stress
University Hospital, Strasbourg, FranceSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Oxidative Stress cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Beni-Suef University | Phase 2/3 | B |
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN University Hospital, Strasbourg, France | Phase 2 | CCC |
VITAMIN D Sint Franciscus Gasthuis | N/A | D |
NEPENTHE Maryam Ekramzadeh, PhD | N/A | D |
METAMIZOLE Maryam Ekramzadeh, PhD | N/A | D |
DEXKETOPROFEN Maryam Ekramzadeh, PhD | N/A | D |
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →